Improvement of non-small-cell lung cancer staging by means of positron emission tomography

Thoracic and Cardiovascular Surgeon

Volumn 47, Issue 1, 1999, Pages 42-47

  Albes, Johannes M ^a   Lietzenmayer, R ^b   Schott, U ^b   Schulen E ^b   Wehrmann, M ^b   Ziemer, G ^b  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; ARTICLE; CANCER INVASION; CANCER STAGING; CLINICAL ARTICLE; HUMAN; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; LYMPHADENOPATHY; MEDIASTINOSCOPY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA;

EID: 0032897606     PISSN: 01716425     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1013107     Document Type: Article

References (22)

1. Miller BA, Ries LAG, Hankey BF et al, eds. SEER Cancer statistics review: 1973-1990. National Cancer Institute. NIH Pub. No. 93-2789; 1993.
2. Shaw GL, Mulshine JL. General strategies for early detection: new ideas and future directions. In: Pass HI, Mitchell JB, Johnson DH, Turrisi AT, eds. Lung Cancer: Principles and Practice. Philadelphia: Lippincott-Raven; 1996: 329-40.
3. Gail MH, Egan RT, Feld R, et al. Prognostic factors in patients with resected stage I non-small cell lung cancer: a report from the Lung Cancer Study Group. Cancer. 1984; 54 : 1802.
4. Luketich JD, Ginsberg RJ. Limited resection versus lobectomy for stage I non-small cell lung cancer. In: Pass HI, Mitchell JB, Johnson DH, Turrisi AT, eds. Lung Cancer: Principles and Practice. Philadelphia: Lippincott-Raven; 1996: 561-6.
5. Webb WR, Gatsonis C, Zerhouni EA, Heelan RT, Glazer GM, Francis R, McNeil BJ. CT and MR imaging in staging non-small cell bronchogenic carcinoma: Report of the Radiologic Diagnostic Oncology Group. Radiology. 1991 ; 178 : 705-13.
6. Patterson GA. Lung cancer staging. Chest. 1991 ; 100 : 520-2.
7. Scott WJ, Gobar LS, Terry JD, Dewan NA, Sunderland JJ. Mediastinal lymph node staging of non-small-cell lung cancer: a prospective comparison of computed tomography and positron emission tomography. J Thorac Cardiovasc Surg. 1996; 111 : 642-8.
8. Warburg O. On the origin of cancer cells. Science. 1956; 123 : 309-1 4.
9. Kubota K, Matzusawa T, Ito M, et al. Lung tumor imaging by positron emission tomography using C-11 L-methionine. J Nucl Med. 1985;26 : 37-42.
10. Abe Y, Matzusawa T, Fujiwara T, et al. Clinical assessment of therapeutic effects on cancer using 18F-2-fluoro-2-deoxy-D-glucose and positron emission tomography: preliminary study of lung cancer. Int J Radiat Oncol Biol Phys. 1990;19:1005-10.
11. Nolop KB, Rhodes CG, Brudin LH, et al. Glucose utilization in vivo by human pulmonary neoplasms. Cancer. 1987;60:2682-9.
12. Kubota K, Matsuzawa T, Ito M, et al. Differential diagnosis of lung tumor with positron emission tomography: a prospective study. J Nucl Med. 1990;31 : 1927-32.
13. 18F-fluorodesoxyglucose positron emission tomography in preoperative evaluation of lung cancer. Lancet. 1994;344 : 1265-6.
14. Duhaylongsod FG, Lowe VJ, Patz EF jr., et al. Detection of primary and recurrent lung cancer by means of 18F fluorodesoxyglucose positron emission tomography (FDG PET). J Thorac Cardiocvasc Surg. 1995;110:130-40.
15. Sasaki M, Ichiya Y, Kuwabara Y, et al. The usefulness of FDG positron emission tomography for the detection of mediastinal lymph node metastases in patients with non-small cell lung cancer: a comparative study with X-ray computed tomography. Eur J Nucl Med. 1996;23 : 741-7.
16. Guhlmann A, Storck M, Kotzerke J, Moog F, Sunder-Plassmann L, Reske SN. Lymph node staging in non-small cell lung cancer: evaluation by [18F]FDG positron emission tomography (PET). Thorax. 1997;52:438-41.
17. Mountain CF. A new international staging system for lung cancer. Chest. 1986;89 : 225 S.
18. Moore DF jr., Soo Lee J. Staging and prognostic factors: Non-small cell lung cancer. In: Pass HI, Mitchell JB, Johnson DH, Turrisi AT, eds. Lung Cancer: Principles and Practice. Philadelphia: Lippincott-Raven; 1996 : 481-94.
19. Little AG, Stitik FP. Clinical staging of patients with non-small cell lung cancer. Chest. 1990;97 : 1431 -8.
20. Bury T, Paulus P, Dowlati A, et al. Staging of the mediastinum: value of positron emission tomography imaging in non-small cell lung cancer. Eur Respir J. 1996;9 : 2560-4.
21. McLoud TC, Bourgouin PM, Greenberg RW, Kosiuk JP, Templeton PA, Shepard JO, Moore EH, Wain JC, Mathisen DJ, Grillo HC. Bronchogenic carcinoma: Analysis of staging in the mediastinum with CT by correlative lymph node mapping and sampling. Radiology. 1992;182:319-23.
22. Steinert HC, Hauser M, Allemann F, Engel H, Berthold T, v. Schulthess GK, Weder W. Non-small cell lung cancer: Nodal staging with FDG PET versus CT with correlative lymph node mapping and sampling. Radiology. 1997:202 : 441-6.